| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.55 | 0.04 |